Viewing Study NCT06464705



Ignite Creation Date: 2024-07-17 @ 11:27 AM
Last Modification Date: 2024-10-26 @ 3:32 PM
Study NCT ID: NCT06464705
Status: RECRUITING
Last Update Posted: 2024-06-20
First Post: 2024-06-13

Brief Title: To Investigate the Effect of PEMF for Pateitns After Anterior Cruciate Ligament Reconstruction With Hamstring Autograft
Sponsor: Chinese University of Hong Kong
Organization: Chinese University of Hong Kong

Study Overview

Official Title: Effect of Pulsed Electromagnetic Fields on Promoting Hamstring Muscle Strength After Anterior Cruciate Ligament Reconstruction With Hamstring Autograft A Double-Blind Placebo-Controlled Randomised Clinical Trial
Status: RECRUITING
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Anterior cruciate ligament ACL tear is common It accounts for over 50 of all knee injuries Anterior cruciate ligament reconstruction ACLR with hamstring tendon HT autograft is the common graft choice for ACLR However the outcomes of donor site healing and recovery of muscle strength of HT are not satisfactory resulting in hamstring muscle weakness and hamstring strength deficit during deep knee flexion which may lead to hamstring strain after ACLR Moreover activation of the hamstring muscle is vital for maintaining dynamic knee joint stability and preventing excessive ACL shear forces The presence of hamstring muscle deficits after surgery therefore affects the function of the reconstruction ACL A previous study has reported that the hamstring muscle showed nearly 20 strength deficit at 4 months after ACLR with hamstring autograft

Pulsed electromagnetic field PEMF treatment is a non-invasive therapy that has been shown to enhance muscle cell activity and accelerate tissue repair In clinic PEMF treatment has been reported to be safe

This study aims to conduct a double-blinded placebo-controlled randomised clinical trial to investigate the effects of PEMF therapy for improving the tissue regeneration and strength of the HT donor site in ACLR patients with HT autograft
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None